HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
Jessica N McAlpine, Kimberly C Wiegand, Russell Vang, Brigitte M Ronnett, Anna Adamiak, Martin Köbel, Steve E Kalloger, Kenneth D Swenerton, David G Huntsman, C Blake Gilks, Dianne M MillerVolume:
9
Langue:
english
DOI:
10.1186/1471-2407-9-433
Date:
December, 2009
Fichier:
PDF, 1.20 MB
english, 2009
File converter
Plus de résultats de recherche
More benefits 
